financetom
Business
financetom
/
Business
/
Molecular Partners Prices $20 Million Offering of American Depositary Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Molecular Partners Prices $20 Million Offering of American Depositary Shares
Nov 3, 2024 11:19 AM

03:43 AM EDT, 10/25/2024 (MT Newswires) -- Molecular Partners ( MOLN ) said Friday it priced an underwritten offering in the US of 3.6 million American depositary shares, each representing one ordinary share, at $5.49 per ADS for gross proceeds of about $20 million.

Proceeds from the offering, expected to close on Oct. 29, will be used to develop and expand the company's radiopharmaceutical pipeline and platform and for general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Two Republicans want Pentagon to add Chinese battery maker CATL to restricted list
Two Republicans want Pentagon to add Chinese battery maker CATL to restricted list
Aug 30, 2024
WASHINGTON (Reuters) - Two top Republican lawmakers on Wednesday asked the U.S. Defense Department to add Chinese battery maker CATL to a restricted list of companies allegedly working with Beijing's military. Companies added to the list cannot receive U.S. military contracts. Senator Marco Rubio, the vice chair of the Intelligence Committee and Representative John Moolenaar who chairs the House Select...
Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug
Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug
Aug 30, 2024
01:01 PM EDT, 08/28/2024 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) shares declined Wednesday after scoring a partial victory in a legal fight with Jazz Pharmaceuticals ( JAZZ ) over Avadel's bid to commercialize its Lumryz medication for the treatment of excessive daytime sleepiness in adults with narcolepsy. In a ruling on Tuesday, federal Judge Gregory Williams sided with...
Tylenol maker defeats lawsuit over labeling
Tylenol maker defeats lawsuit over labeling
Aug 30, 2024
NEW YORK (Reuters) - The maker of Tylenol defeated a lawsuit by consumers who said they were deceived into overpaying for Rapid Release gelcaps that did not relieve pain faster than cheaper tablets, including those labeled Extra Strength and Regular Strength. In a decision on Tuesday night, U.S. District Judge Andrew Carter in Manhattan agreed with Kenvue ( KVUE )...
--Street Color: United Airlines' Flight Attendants Vote 99.99% to Authorize Strike, Union Says
--Street Color: United Airlines' Flight Attendants Vote 99.99% to Authorize Strike, Union Says
Aug 30, 2024
01:20 PM EDT, 08/28/2024 (MT Newswires) -- Price: 41.48, Change: -0.66, Percent Change: -1.57 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved